Discovery of novel and selective farnesoid X receptor antagonists through structure-based virtual screening, preliminary structure-activity relationship study, and biological evaluation
-
Published:2024-04
Issue:
Volume:269
Page:116323
-
ISSN:0223-5234
-
Container-title:European Journal of Medicinal Chemistry
-
language:en
-
Short-container-title:European Journal of Medicinal Chemistry
Author:
Dou Xiaodong,
Huo Tongyu,
Liu Yameng,
Pang Zichen,
Su Lingyu,
Zhao Xinyi,
Peng Xing,
Liu Zhenming,
Zhang Liangren,
Jiao NingORCID
Reference51 articles.
1. Recent advances on FXR-targeting therapeutics;Panzitt;Mol. Cell. Endocrinol.,2022
2. Farnesoid X receptor: a potential therapeutic target in multiple organs;Zhang;Histol. Histopathol.,2020
3. Farnesoid X receptor: a "homeostat" for hepatic nutrient metabolism;Massafra;Biochim. Biophys. Acta, Mol. Basis Dis.,2018
4. FXR: a metabolic regulator and cell protector;Wang;Cell Res.,2008
5. Hepatic FXR: key regulator of whole-body energy metabolism;Teodoro;Trends Endocrinol Metab,2011